Nijhawan Pardeep

Chief Executive Officer

Nijhawan Pardeep has filed 21 SEC Form 4 filings (24 transaction rows) across 1 company, with disclosures dating back to 2025. 20 of those filings fall inside the rolling window. Most recent filing: Sep 1, 2026.

On the most recent filing, Nijhawan Pardeep is listed as Chief Executive Officer at Edesa Biotech, Inc. Inside the rolling window, Nijhawan Pardeep reported 7 open-market purchases totaling $230K in EDSA and no open-market sales. The largest disclosed transaction in the window is a purchase of 30,000 EDSA shares on Feb 27, 2026, worth $67K.

Companies traded

Other insiders at EDSA

Insider Buying

$230K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
EDSAPurchase$7KMar 10SEC ↗
EDSAPurchase$39KMar 6SEC ↗
EDSAPurchase$43KMar 5SEC ↗
EDSAPurchase$36KMar 4SEC ↗
EDSAPurchase$6KMar 3SEC ↗
EDSAPurchase$32KMar 2SEC ↗
EDSAPurchase$67KMar 2SEC ↗
Showing 1–7 of 7
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Nijhawan Pardeep made?

Nijhawan Pardeep has filed 21 SEC Form 4 filings (24 transaction rows) across 1 company since 2025.

Which companies does Nijhawan Pardeep trade?

Nijhawan Pardeep has filed SEC Form 4 disclosures for 1 company, including EDSA.

When was Nijhawan Pardeep's most recent SEC Form 4 filing?

Nijhawan Pardeep's most recent SEC Form 4 filing on Tracefour is dated Sep 1, 2026.

What is Nijhawan Pardeep's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Nijhawan Pardeep is listed as Chief Executive Officer.

What is Nijhawan Pardeep's total buy and sell value in the current window?

Inside the rolling retention window, Nijhawan Pardeep bought $230K and sold $0 based on SEC Form 4 filings.

What was Nijhawan Pardeep's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 30,000 EDSA shares on 2026-02-27, worth $67K, per SEC Form 4 filings.